anemia/1000
Instructed in new medication Sinemet and in S/E such as choreiform, dystonic, dyskinetic movements, involuntary grimacing, head movements, myoclonic body jerks, ataxia, tremor, muscle twitching, bradykinetic episodes, psychiatric disturbances, anxiety, disturbing dreams, euphoria, malaise, fatigue, severe depression, suicidal tendencies, dementia, delirium, hallucinations (may necessitate reduction or withdrawal of drug), confusion, insomnia, agitation, orthostatic hypotension, cardiac irregularities, phlebitis, blepharospasm, blurred vision, diplopia, mydriasis or miosis, oculogyric crises, excessive salivation, dry mouth, bitter taste, nausea, vomiting, anorexia, constipation, flatulence, diarrhea, abdominal pain, urinary frequency, urine retention, urinary incontinence, darkened urine, priapism, hemolytic anemia, thrombocytopenia, leukopenia, agranulocytosis, hepatotoxicity, weight loss (may occur at start of therapy), hiccups, hyperventilation, and dark perspiration.
Instructed in new medication Feroso to manage anemia. In addition, warned of possible S/E such as nausea, vomiting, constipation, GI discomfort, headache, dizziness, dry mouth, rash and others.
Instructed in new medication Actos to improve glycemic control. In addition, warned of possible S/E such as headache, edema, heart failure, sinusitis, pharyngitis, tooth disorder, anemia, hypoglycemia (with combination therapy), aggravated diabetes mellitus, weight gain, myalgia and upper respiratory tract infection.
Instructed in vitamin B12, ordered to management anemia and in S/E such as itching, urticaria, pain or burning in injection sites, transient diarrhea, transitory exanthema, etc.
Instructed in new medication Tylenol to manage mild pain or fever. In addition, warned of possible S/E such as hemolytuc anemia, neutropenia, leukopenia, pancytopenia, liver damage, jaundice, hypoglycemia, rash and urticaria. Consult prescriber before giving drug to children younger than age 2. Tylenol is only for short-term use. Consult prescriber if it is given to children for longer than 5 days or adults for longer than 10 days. Instructed not to use for marked fever (higher than 103.1 F), fever persisting longer than 3 days, or recurrent fever unless it is directed by prescriber. Warned that high doses or unsupervised long-term use can cause hepatic damage. Excessive ingestion of alcohol may increase the risk of hepatotoxicity. Breast-feeding women: acetaminophen appears in breast milk in low levels (less than 1% of dose). Drug may be used safely if therapy is short-term and does not exceed recommended doses.
A diet that meets the dietary guidelines will ordinarily have enough iron, folate, and vitamin Bto prevent anemia.
Patient was instructed on factors that contributes to poor skin integrity, such as, immobilization, poor circulation, moisture, heat, anemia, shearing forces poor nutritional status, etc.
Taught that Folic Acid helps to relieve symptoms such as unusual tiredness and diarrhea that can occur with some types of anemia.
Taught that anemia and obesity are factors that may increase the risk of developing/exacerbating Congestive Heart Failure (CHF).
SN advised patient and caregiver that arixtra can cause fever or anemia. Both of them verbalized understanding of instructions given.